Literature DB >> 3297526

Theophylline and mucociliary clearance.

I Ziment.   

Abstract

Abnormal mucociliary transport is improvement by the action of theophylline, and this effect can be attributed to several mechanisms. The drug may directly and indirectly mediate the increase in the secretory output of bronchial glands, and this effect is enhanced by the vagal gastropulmonary reflex which is stimulated by the irritant action of theophylline on the stomach. Theophylline can increase the transepithelial secretion of fluid into the respiratory tract lumen by stimulating the chloride pump which is controlled by cyclic AMP. Ciliary motility is stimulated by theophylline; most of this effect is confined to the proximal part of the respiratory tree. However, much of the improvement in mucociliary clearance may be a consequence of the bronchodilation induced by theophylline, since the improved airway patency is generally a prerequisite for enhanced mucokinesis. Nevertheless, the multiple sites of action of theophylline in the respiratory tract suggests that this drug should be considered to be of significant value in any disorder characterized by mucostasis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297526     DOI: 10.1378/chest.92.1_supplement.38s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Uses and abuses of theophylline.

Authors:  T W Rosenal
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

2.  Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary disease.

Authors:  Marie-Christyne Cyr; Marie-France Beauchesne; Catherine Lemière; Lucie Blais
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

Review 3.  Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease.

Authors:  David R Curran; Lauren Cohn
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

Review 4.  The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review.

Authors:  Jill A Ohar; James F Donohue; Selwyn Spangenthal
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

Review 5.  Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections.

Authors:  Helmut H Albrecht; Peter V Dicpinigaitis; Eric P Guenin
Journal:  Multidiscip Respir Med       Date:  2017-12-11

Review 6.  Purinergic Signaling in Mast Cell Degranulation and Asthma.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Front Pharmacol       Date:  2017-12-22       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.